147 related articles for article (PubMed ID: 34764106)
1. Epstein-Barr virus-induced natural killer/T cell lymphoma arising in tonsil and cervical node tissue.
Santos AT; Tong J; Steinberg A; Shemen L
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764106
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic outcome of Epstein-Barr virus positive T/NK cell lymphoma in the upper aerodigestive tract.
Hahn JS; Lee ST; Min YH; Ko YW; Yang WI; Kim GE
Yonsei Med J; 2002 Apr; 43(2):175-82. PubMed ID: 11971211
[TBL] [Abstract][Full Text] [Related]
3. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
Chuang SS
Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
[TBL] [Abstract][Full Text] [Related]
4. A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphoma.
Sugimoto KJ; Shimada A; Wakabayashi M; Imai H; Sekiguchi Y; Nakamura N; Sawada T; Ota Y; Takeuchi K; Ito Y; Kimura H; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(1):411-7. PubMed ID: 24427365
[TBL] [Abstract][Full Text] [Related]
5. Nasal and nasal-type natural killer (NK)/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association.
Peh SC; Quen QW
Med J Malaysia; 2003 Jun; 58(2):196-204. PubMed ID: 14569739
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
7. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
9. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract.
Ott G; Kalla J; Ott MM; Müller-Hermelink HK
Diagn Mol Pathol; 1997 Jun; 6(3):134-9. PubMed ID: 9276184
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
13. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.
Siddiquey MN; Nakagawa H; Iwata S; Kanazawa T; Suzuki M; Imadome K; Fujiwara S; Goshima F; Murata T; Kimura H
Cancer Sci; 2014 Jun; 105(6):713-22. PubMed ID: 24712440
[TBL] [Abstract][Full Text] [Related]
15. How we treat NK/T-cell lymphomas.
Tse E; Zhao WL; Xiong J; Kwong YL
J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups.
Cho EY; Kim KH; Kim WS; Yoo KH; Koo HH; Ko YH
J Korean Med Sci; 2008 Apr; 23(2):185-92. PubMed ID: 18436998
[TBL] [Abstract][Full Text] [Related]
17. Nasal natural killer lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus.
Canioni D; Arnulf B; Asso-Bonnet M; Raphael M; Brousse N
Arch Pathol Lab Med; 2001 May; 125(5):660-2. PubMed ID: 11300939
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
[TBL] [Abstract][Full Text] [Related]
20. Extranodal malignant lymphoma of the upper aerodigestive tract: prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital.
Assanasen T; Wannakrairot P; Keelawat S; Ruangvejvorachai P; Pramprayoon N
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S266-73. PubMed ID: 16623040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]